Disclosure Of First-Time Adoption [Text Block]

Pharming Group N.V. - Filing #1859781

Concept As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
273,167,000 USD
2,283,000 USD
192,916,000 USD
1,316,000 USD
402,000 USD
455,254,000 USD
3,965,000 USD
7,429,000 USD
295,621,000 USD
USD
7,312,000 USD
622,000 USD
19,037,000 USD
447,130,000 USD
4,955,000 USD
183,435,000 USD
USD
4,081,000 USD
441,951,000 USD
117,388,000 USD
340,715,000 USD
USD
4,845,000 USD
7,226,000 USD
Comprehensive income
2,283,000 USD
USD
270,000 USD
15,072,000 USD
USD
USD
1,089,000 USD
15,996,000 USD
52,702,000 USD
37,746,000 USD
USD
USD
USD
USD
14,956,000 USD
USD
Profit (loss)
USD
USD
USD
USD
USD
USD
15,996,000 USD
15,996,000 USD
37,746,000 USD
37,746,000 USD
USD
USD
USD
USD
USD
USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.